Antibodies have been used to prevent or treat viral infections since the nineteenth century,
but the full potential to use passive immunization for infectious diseases has yet to be …

Hendra virus (HeV) and Nipah virus (NiV) are biosafety level 4 zoonotic pathogens causing
severe and often fatal neurological and respiratory disease. These agents have been …

Nipah virus (NiV) and Hendra virus (HeV) are highly pathogenic zoonotic henipaviruses
(HNVs) responsible for recurrent outbreaks of encephalitis and respiratory illness. As the …

We identified and isolated a novel Hendra virus (HeV) variant not detected by routine testing
from a horse in Queensland, Australia, that died from acute illness with signs consistent with …

Langya virus (LayV) is a recently discovered henipavirus (HNV), isolated from febrile
patients in China. HNV entry into host cells is mediated by the attachment (G) and fusion (F) …

Nipah virus (NiV) represents a significant pandemic threat with zoonotic transmission from
bats-to-humans with almost annual regional outbreaks characterized by documented human …

Hendra virus (HeV) and Nipah virus (NiV) are deadly zoonotic Henipaviruses (HNVs)
responsible for recurrent outbreaks in humans and domestic species of highly fatal (50 to …

Hantaviruses are high-priority emerging pathogens carried by rodents and transmitted to
humans by aerosolized excreta or, in rare cases, person-to-person contact. While infections …

Abstract Langya Henipavirus (LayV) infection is an emerging zoonotic disease that has
been causing respiratory symptoms in China since 2019. For virus entry, LayV's genome …

Since the first approval of monoclonal antibodies by the United States Food and Drug
Administration (FDA) in 1986, therapeutic antibodies have become one of the predominant …